Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ICML 2019 | Dutch HOVON lymphoma study group update

Pieternella Lugtenburg • 20 Jun 2019
ICML 2019
B-Cell Lymphoma Diffuse Large B-Cell Lymphoma Lymphoma Non-Hodgkin Lymphoma Viral Lymphoma

Pieternella Lugtenburg, MD, PhD, Erasmus University Medical Center, Rotterdam, Netherlands, discusses the current research of the Dutch HOVON lymphoma study group. She covers diffuse large B-cell lymphoma (DLBCL), double-hit lymphoma, and Burkitt’s lymphoma. This interview took place at the 15th International Conference on Malignant Lymphoma (ICML), in Lugano, Switzerland.

More from Pieternella Lugtenburg

1:52
Rituximab maintenance shows no advantage over observation in DLBCL
Pieternella Lugtenburg • 20 Jun 2019
2:07
Treatment of aggressive NHL in frail patients: cardiac comorbidities and advanced age
Pieternella Lugtenburg • 20 Jun 2019

Related Videos

3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
2:11
The role of CAR-T therapy for lymphoma in 2024: expert session highlights
Sridhar Chaganti • 16 Apr 2024
1:32
Promising novel immunotherapeutic approaches in lymphoma
Gloria Iacoboni • 15 Apr 2024
3:03
AlloSCT outcomes after immunotherapy vs chemotherapy in patients with R/R NHL: a retrospective study
Jacopo Mariotti • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals